Literature DB >> 27826639

Parity as a predictor of obstetric fistula classification.

Erin Lorencz1, Shelley L Galvin2, Andrew Browning3, Hannah Krause4, Judith Goh4,5.   

Abstract

INTRODUCTION AND HYPOTHESIS: Obstetric fistulas are injuries to the genital tract in women without emergency obstetric services. Parity may predict the characteristics of fistulas that affect closure success and residual incontinence. Circumferential fistulas may predispose patients to postoperative incontinence. We hypothesized that primiparous women have more distal fistulas than multiparous women, leading to more scarring and circumferential fistulas.
METHODS: A retrospective observational study was conducted on 1,856 women with obstetric fistula evaluated at three sites by three providers. Fistulas were classified using the Goh classification system. Women aged 10 to 55 years were classified as primiparas or multiparas. Analysis by parity of fistula type and size, degree of scarring, and presence of circumferential defect used the Chi squared or Fisher's exact test, and binary logistic regression.
RESULTS: Of the 1,841 (99.2 %) women included, 878 (47.7 %) were primiparas and 963 (52.3 %) were multiparas. Primiparas were more likely to have distal fistulas, type 4 being most common (31.5 %), whereas multiparas were more likely to have proximal fistulas, most commonly type 1 (48.1 %). Primiparas were more likely to have moderate to severe scarring (11.7 % vs 5.6 %; p < 0.001), and category III (57.1 % vs 39.2 %; p < 0.001), but not to develop circumferential fistulas (5.6 % vs 4.0 %; p = 0.127), be present for repeat surgery (7.1 % vs 7.6 %; p = 0.721), or have ureteric involvement (1.5 % vs 2.2 %; p = 0.301). Multivariate analyses confirmed increased risk with primiparity for distal fistula and scarring.
CONCLUSIONS: As hypothesized, primiparas were more likely to have distal fistulas and more scarring, but were not more likely to have circumferential fistulas. Surgeons should plan accordingly.

Entities:  

Keywords:  Obstetric fistula; Parity; Vesico-vaginal fistula

Mesh:

Year:  2016        PMID: 27826639     DOI: 10.1007/s00192-016-3197-z

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  8 in total

Review 1.  Factors influencing urinary fistula repair outcomes in developing countries: a systematic review.

Authors:  Vera Frajzyngier; Joseph Ruminjo; Mark A Barone
Journal:  Am J Obstet Gynecol       Date:  2012-02-20       Impact factor: 8.661

2.  Determinants of postoperative outcomes of female genital fistula repair surgery.

Authors:  Mark A Barone; Vera Frajzyngier; Joseph Ruminjo; Frank Asiimwe; Thierno Hamidou Barry; Abubakar Bello; Dantani Danladi; Sanda Oumarou Ganda; Sa'ad Idris; Maman Inoussa; Maura Lynch; Felicity Mussell; Dulal Chandra Podder
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

3.  Obstetric fistula in 14,928 Ethiopian women.

Authors:  Mulu Muleta; Svein Rasmussen; Torvid Kiserud
Journal:  Acta Obstet Gynecol Scand       Date:  2010-07       Impact factor: 3.636

4.  Classification of female genito-urinary tract fistula: Inter- and intra-observer correlations.

Authors:  Judith T W Goh; Hannah G Krause; Andrew Browning; Allan Chang
Journal:  J Obstet Gynaecol Res       Date:  2009-02       Impact factor: 1.730

5.  Predicting the risk of failure of closure of obstetric fistula and residual urinary incontinence using a classification system.

Authors:  Judith T W Goh; Andrew Browning; Birhanu Berhan; Allan Chang
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-08-09

6.  Risk factors for developing residual urinary incontinence after obstetric fistula repair.

Authors:  A Browning
Journal:  BJOG       Date:  2006-02-20       Impact factor: 6.531

7.  Genital tract fistula repair on 116 women.

Authors:  J T Goh
Journal:  Aust N Z J Obstet Gynaecol       Date:  1998-05       Impact factor: 2.100

8.  The circumferential obstetric fistula: characteristics, management and outcomes.

Authors:  A Browning
Journal:  BJOG       Date:  2007-07-06       Impact factor: 6.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.